Known targets — ChEMBL curated mechanism
ABCC8ACEADORA1ADORA2AADORA2BADORA3ALDH5A1ALOX5ALOX5APATP4AATP4BBRAFCA1CA12CA2CA4CYSLTR1DHFRDPEP1EDNRAEDNRBESR2F10FDPSFGF1GABBR1GABBR2GABRA1GABRA2GABRA3GABRA4GABRA5GABRA6GABRB1GABRB2GABRB3GABRDGABREGABRG1GABRG2GABRG3GABRPGABRQGARTGNRHRGSC1HMGCRIMPDH1IMPDH2KCNJ11LY96NOD2NR3C1NS3NS4ANS5bP2RY1P2RY12P2RY2P2RY4P2RY6PBP2XPDE3APDE3BPDE4APDE4BPDE4CPDE4DPDK1PDK2PDK3PDK4PPARGPPATPTGIRPTGS1PTGS2RAF1RYR1RYR3SCN10ASCN11ASCN1ASCN2ASCN3ASCN4ASCN5ASCN7ASCN8ASCN9ASERPINC1SLC12A1SLC12A3SYKTHRATHRBTLR3TLR4TLR9TUBA1ATUBA1BTUBA1CTUBA3CTUBA3ETUBA4ATUBBTUBB1TUBB2ATUBB2BTUBB3TUBB4ATUBB4BTUBB6TUBB8TYMSVKORC1XDHblablaIMP-1blaOXA-33blaOXA-58blaT-3blaT-4blaT-5blaT-6dacAdacBdacCfolAfolPfolP1ftsIfusAgaggyrAgyrBmecAmrcAmrcBmrdApbp1apbp1bpbp2pbp2apbp2bpbp3pbp4pbpApbpBpbpCpbpFpolponBrplArplBrplCrplDrplErplFrplJrplKrplLrplMrplNrplOrplPrplQrplRrplSrplTrplUrplVrplWrplXrplYrpmArpmBrpmCrpmDrpmErpmFrpmGrpmHrpmIrpmJrpoArpoBrpoCrpoZrpsArpsBrpsCrpsDrpsErpsFrpsGrpsHrpsIrpsJrpsKrpsLrpsMrpsNrpsOrpsPrpsQrpsRrpsSrpsTrpsUykgMykgO
The experimentally established mechanism targets of None. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ESR2 known ✓ | Q92731 | 1/20 | 0.33 |
| ▸ | KDM1A | O60341 | 3/20 | 0.77 |
| ▸ | RCOR1 | Q9UKL0 | 2/20 | 0.70 |
| ▸ | LDHB | P07195 | 4/20 | 0.37 |
| ▸ | KEAP1 | Q14145 | 2/20 | 0.34 |
| ▸ | TERF2IP | Q9NYB0 | 2/20 | 0.34 |
| ▸ | F11 | P03951 | 3/20 | 0.33 |
| ▸ | NPY1R | P25929 | 1/20 | 0.33 |
| ▸ | NPY2R | P49146 | 1/20 | 0.33 |
| ▸ | NPY4R | P50391 | 1/20 | 0.33 |
| ▸ | NPY5R | Q15761 | 1/20 | 0.33 |
| ▸ | ESR1 | P03372 | 1/20 | 0.33 |
| ▸ | BECN1 | Q14457 | 2/20 | 0.33 |
| ▸ | HDAC3 | O15379 | 1/20 | 0.33 |
| ▸ | HDAC4 | P56524 | 1/20 | 0.33 |
| ▸ | HDAC1 | Q13547 | 1/20 | 0.33 |
| ▸ | HDAC7 | Q8WUI4 | 1/20 | 0.33 |
| ▸ | HDAC2 | Q92769 | 1/20 | 0.33 |
| ▸ | HDAC10 | Q969S8 | 1/20 | 0.33 |
| ▸ | HDAC11 | Q96DB2 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL15873843 | 1.00 | KDM1A (0.77) | KDM1ARCOR1LDHBKEAP1TERF2IP | |
| SCHEMBL2476060 | 1.00 | KDM1A (0.77) | KDM1ARCOR1LDHBKEAP1TERF2IP | |
| Sulfuric Acid SCHEMBL28198732 | 0.99 | KDM1A (0.76) | KDM1ARCOR1LDHBKEAP1TERF2IP | |
| SCHEMBL28868015 | 0.96 | KDM1A (0.83) | KDM1ARCOR1LDHBKEAP1TERF2IP | |
| SCHEMBL20240509 | 0.95 | KDM1A (0.69) | KDM1ARCOR1LDHBKEAP1TERF2IP | |
| SCHEMBL119883 | 0.94 | KDM1A (0.79) | KDM1ARCOR1LDHBKEAP1TERF2IP | |
| SCHEMBL31087460 | 0.91 | KDM1A (0.84) | KDM1ARCOR1LDHBKEAP1TERF2IP | |
| SCHEMBL16281102 | 0.89 | KDM1A (0.83) | KDM1ARCOR1LDHBKEAP1TERF2IP | |
| Sulfuric Acid SCHEMBL14637227 | 0.88 | KDM1A (0.95) | KDM1ARCOR1LDHBKEAP1TERF2IP | |
| Sulfuric Acid SCHEMBL11906224 | 0.88 | KDM1A (0.95) | KDM1ARCOR1LDHBKEAP1TERF2IP |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Appears in 3386 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12616803-B2 | Apparatus for dispensing inhalant medicament | METOPI PHARMACEUTICALS, INC. (US) | 2026-05-05 | — | — | US | claimed |
| US-20250375581-A1 | APPARATUS FOR DISPENSING INHALANT MEDICAMENT | METOPI PHARMACEUTICALS, INC. | 2025-12-11 | — | — | US | claimed |
| US-20250213511-A1 | BACTERICIDAL AND VIRUCIDAL PHARMACEUTICAL COMPOSITION | QUIMICA LUAR SRL (AR) | 2025-07-03 | — | — | US | claimed |
| US-12220440-B2 | Drug composition, method for treating infection, disinfecting composition, and drug adjuvant | CITY UNIVERSITY OF HONG KONG (HK) | 2025-02-11 | — | — | US | claimed |
| US-12178841-B2 | Treatment of non-cystic fibrosis bronchiectasis | ZAMBON S.P.A. (IT) | 2024-12-31 | — | — | US | claimed |
| US-20240342239-A1 | TREATMENT OF NON-CYSTIC FIBROSIS BRONCHIECTASIS | ZAMBON S.P.A. (IT) | 2024-10-17 | — | — | US | claimed |
| US-20240325332-A1 | BACTERICIDAL AND VIRUCIDAL PHARMACEUTICAL COMPOSITION | QUIMICA LUAR SRL (AR) | 2024-10-03 | — | — | US | claimed |
| US-20240282425-A1 | AUTHENTICATION METHODS AND SYSTEMS FOR DISPENSED PRESCRIPTIONS | LOW GORDON KEITH (US) | 2024-08-22 | — | — | US | claimed |
| US-12059431-B2 | Combination therapies that enhance antimicrobial/anticancer activities | INTERNATIONAL BUSINESS MACHINES CORPORATION (US) | 2024-08-13 | — | — | US | claimed |
| CN-118410628-A | Water resource optimal allocation method in radial power distribution system | 浙江禹贡信息科技有限公司 | 2024-07-30 | — | — | CN | claimed |
| US-6248363-B1 | Improved delivery of hydrophilic or hydrophobic pharmaceutical active ingredients, such as drugs, nutraceuticals, cosmeceuticals and diagnostic agents | LIPOCINE, INC. | 2001-06-19 | — | — | US | claimed |
| WO-2001037808-A1 | SOLID CARRIERS FOR IMPROVED DELIVERY OF ACTIVE INGREDIENTS IN PHARMACEUTICAL COMPOSITIONS | LIPOCINE, INC. (US) | 2001-05-31 | — | — | WO | claimed |
| WO-2001028555-A1 | EMULSION COMPOSITIONS FOR POLYFUNCTIONAL ACTIVE INGREDIENTS | LIPOCINE, INC. (US) | 2001-04-26 | — | — | WO | claimed |
| EP-1087989-A1 | IMPROVED PROCESS FOR PREPARING SCHIFF BASE ADDUCTS OF AMINES WITH O-HYDROXY ALDEHYDES AND COMPOSITIONS OF MATTER BASED THEREON | Pfizer Products Inc. (US) | 2001-04-04 | — | — | EP | claimed |
| WO-2001012155-A1 | COMPOSITIONS AND METHODS FOR ENHANCED ABSORPTION OF HYDROPHILIC THERAPEUTIC AGENTS | LIPOCINE, INC. (US) | 2001-02-22 | — | — | WO | claimed |
| WO-2000071175-A1 | OPHTHALMIC SOLUTIONS INCORPORATING AN ANTIMICROBIAL POLYPEPTIDE | LARGE SCALE BIOLOGY CORPORATION (US) | 2000-11-30 | — | — | WO | claimed |
| CN-1048393-C | Aqueous drug composition having property of reversible thermosetting gelation | WAKAMOTO PHARMA CO LTD (JP) | 2000-01-19 | — | — | CN | claimed |
| WO-2000000507-A1 | IMPROVED PROCESS FOR PREPARING SCHIFF BASE ADDUCTS OF AMINES WITH O-HYDROXY ALDEHYDES AND COMPOSITIONS OF MATTER BASED THEREON | PFIZER PRODUCTS INC. (US) | 2000-01-06 | — | — | WO | claimed |
| CN-1097593-A | Aqueous drug composition having property of reversible thermosetting gelation | WAKAMOTO PHARMA CO LTD (JP) | 1995-01-25 | — | — | CN | claimed |
| US-4340671-A | E. coli sensitivity broth | MCDONNELL DOUGLAS CORPORATION (US) | 1982-07-20 | — | — | US | claimed |